First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.25 USD 66.67%
Updated: May 17, 2024

Sonoma Pharmaceuticals Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sonoma Pharmaceuticals Inc
Total Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Total Liabilities
$7.9m
CAGR 3-Years
10%
CAGR 5-Years
16%
CAGR 10-Years
2%
Johnson & Johnson
NYSE:JNJ
Total Liabilities
$101.9B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
6%
Bristol-Myers Squibb Co
NYSE:BMY
Total Liabilities
$82.5B
CAGR 3-Years
3%
CAGR 5-Years
33%
CAGR 10-Years
16%
Pfizer Inc
NYSE:PFE
Total Liabilities
$137.5B
CAGR 3-Years
15%
CAGR 5-Years
7%
CAGR 10-Years
4%
Merck & Co Inc
NYSE:MRK
Total Liabilities
$65.5B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Total Liabilities
$51.1B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
12%

See Also

What is Sonoma Pharmaceuticals Inc's Total Liabilities?
Total Liabilities
7.9m USD

Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Total Liabilities amounts to 7.9m USD.

What is Sonoma Pharmaceuticals Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
2%

Over the last year, the Total Liabilities growth was -5%. The average annual Total Liabilities growth rates for Sonoma Pharmaceuticals Inc have been 10% over the past three years , 16% over the past five years , and 2% over the past ten years .